These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4270070)

  • 21. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique.
    Borgers M; Thoné F; van Nueten JM
    Acta Histochem Suppl; 1981; 24():327-32. PubMed ID: 6165047
    [No Abstract]   [Full Text] [Related]  

  • 22. Resting, exercise and postexercise heart rate and systolic time intervals in normal men treated with lidoflazine.
    De Cock W; Schuermans V; Jageneau A; De Crée J; Brugmans J
    Arzneimittelforschung; 1973 Oct; 23(10):1450-4. PubMed ID: 4591313
    [No Abstract]   [Full Text] [Related]  

  • 23. Quantitative and comparative studies of pharmacological features in the coronary, femoral and renal circulations with different coronary vasodilators.
    Oguro K; Hashimoto K
    Jpn J Pharmacol; 1974 Apr; 24(2):227-33. PubMed ID: 4212295
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of hypoxia-induced rise in adenosine release and flow by coronary dilators.
    Kukovetz WR; Pöch G
    Cardiology; 1971; 56(1):107-13. PubMed ID: 5152736
    [No Abstract]   [Full Text] [Related]  

  • 25. The disappearance of adenosine in blood. Effect of lidoflazine and other drugs.
    Van Belle H
    Eur J Pharmacol; 1970 Jul; 11(2):241-8. PubMed ID: 5447806
    [No Abstract]   [Full Text] [Related]  

  • 26. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
    Plagemann PG; Woffendin C
    Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 2,5-dimethoxy-4-methylamphetamine (DOM, STP) on the uptake and release of 14C-5-hydroxytryptamine by rabbit blood platelets.
    Huang JT; Airaksinen MM; Ho BT
    Eur J Pharmacol; 1974 Feb; 25(2):251-4. PubMed ID: 4435028
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M; D'Angelo A; Mannucci PM; Pareti F; Vanasia S; Viganò
    Clin Ter; 1980 Feb; 92(4):359-68. PubMed ID: 6108818
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibitory effect of two newer antidepressants, Lu 5-003 and Lu 3-010, on serotonin uptake in human blood platelets in vitro.
    Lingjaerde O
    Psychopharmacologia; 1970; 17(1):94-9. PubMed ID: 5421217
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine.
    Pirovano IM; Van Belle H; Ijzerman AP
    Eur J Pharmacol; 1990 Dec; 189(6):419-22. PubMed ID: 2073930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
    Zucker MB; Peterson J
    J Lab Clin Med; 1970 Jul; 76(1):66-75. PubMed ID: 5425364
    [No Abstract]   [Full Text] [Related]  

  • 34. Lidoflazine combined with nucleotide precursors increases ATP content and adenosine production in cardiomyocytes.
    Kalsi KK; Smolenski RT; Yacoub MH
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):279-82. PubMed ID: 16021916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area].
    Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC
    Therapie; 1975; 30(2):185-95. PubMed ID: 1162641
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrocardiographic studies on the drug Clinium].
    Széplaki S; Böszörményi E; Werkner J; Szmandra J
    Orv Hetil; 1974 Jan; 115(1):25-8. PubMed ID: 4809138
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of intravenous lidoflazine on serotonin-induced cerebral vascular contraction--an in vivo study.
    Rosenwasser RH; Tuma RF; Buchheit WA
    Stroke; 1986; 17(4):728-30. PubMed ID: 3738957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic functions of phorbol ester and calcium in serotonin release from human platelets.
    Yamanishi J; Takai Y; Kaibuchi K; Sano K; Castagna M; Nishizuka Y
    Biochem Biophys Res Commun; 1983 Apr; 112(2):778-86. PubMed ID: 6405748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
    Pfleger K; Volkmer I; Kolassa N
    Arzneimittelforschung; 1969 Dec; 19(12):1972-4. PubMed ID: 4985338
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.